Secure 3 Months of GLP-1/GIP Weight-Loss Injections
•
Use Code LUMI50
•
New Patients Only
•
00
DAYS
00
HRS
00
MINS
00
SECS

Personalized Dosing Instructions

ALWAYS follow your physician's prescribed treatment plan. Your Compounded Semaglutide (GLP-1) medication/Compounded Tirzepatide (GLP-1/GIP) medication is a once-a-week injection. Dosage increases are typically prescribed monthly, depending on your weight loss goals and how your body responds to the treatment.

Dosing Guide for Compounded Semaglutide (GLP-1) Injections

(GLISS)
*2.22 mg is the maximum dose/maintenance dose for Compounded Semaglutide (GLP-1) Injections **Increase dose beyond labeled instructions ONLY AS OR IF DIRECTED by provider.
WEEKLY DOSINGSIG / INJECTION INSTRUCTIONS
0.22 mg
Inject 9 units (0.22 mg) SQ weekly for weeks 1-4 Inject 18 units (0.44 mg) SQ weekly for weeks 5-8 Inject 36 units (0.89 mg) SQ weekly for weeks 9-12 Increase dose ONLY AS DIRECTED by provider (not to exceed 1.5 mg SQ weekly)
0.44 mg
Inject 18 units (0.44 mg) SQ weekly for weeks 1-4 Inject 36 units (0.89 mg) SQ weekly for weeks 5-8 Inject 60 units (1.5 mg) SQ weekly for weeks 9-12 Increase dose ONLY AS DIRECTED by provider (not to exceed 2 mg SQ weekly)
0.89 mg
Inject 36 units (0.89 mg) SQ weekly for weeks 1-4 Inject 60 units (1.5 mg) SQ weekly for weeks 5-8 Inject 80 units (2.0 mg) SQ weekly for weeks 9-12 Increase dose ONLY AS DIRECTED by provider (not to exceed 2.22 mg SQ weekly)
1.5 mg
Inject 60 units (1.5 mg) SQ weekly for weeks 1-4 Inject 80 units (2.0 mg) SQ weekly for weeks 5-8 Inject 89 units (2.22 mg) SQ weekly for weeks 9-12 Increase dose ONLY AS DIRECTED by provider (not to exceed 2.4 mg SQ weekly)
2 mg
Inject 80 units (2.0 mg) SQ weekly for weeks 1-4 Inject 89 units (2.22 mg) SQ weekly for weeks 5-8 Inject 89 units (2.22 mg) SQ weekly for weeks 9-12 Increase dose ONLY AS DIRECTED by provider (not to exceed 2.4 mg SQ weekly)
2.22 mg
Inject 89 units (2.22 mg) SQ weekly for weeks 1-4 Inject 89 units (2.22 mg) SQ weekly for weeks 5-8 Inject 89 units (2.22 mg) SQ weekly for weeks 9-12 Increase dose ONLY AS DIRECTED by provider (not to exceed 2.4 mg SQ weekly)

Dosing Guide for Compounded Tirzepatide (GLP-1/GIP) Injections

(GLISS)
*15 mg is the maximum dose/maintenance dose for Compounded Tirzepatide (GLP-1/GIP) Injections **Increase dose beyond labeled instructions ONLY AS OR IF DIRECTED by provider.
WEEKLY DOSINGSIG / INJECTION INSTRUCTIONS
2.22 mg
Inject 22 units (2.22 mg) SQ weekly for weeks 1-4 Inject 45 units (4.45 mg) SQ weekly for weeks 5-8 Inject 67 units (6.67 mg) SQ weekly for weeks 9-12 Increase dose beyond labeled instructions ONLY AS OR IF DIRECTED by provider
4.45 mg
Inject 45 units (4.45 mg) SQ weekly for weeks 1-4 Inject 67 units (6.67 mg) SQ weekly for weeks 5-8 Inject 89 units (8.9 mg) SQ weekly for weeks 9-12 Increase dose beyond labeled instructions ONLY AS OR IF DIRECTED by provider
6.67 mg
Inject 67 units (6.67 mg) SQ weekly for weeks 1-4 Inject 89 units (8.9 mg) SQ weekly for weeks 5-8 Inject 1.11 mL (11.12 mg) SQ weekly for weeks 9-12 Increase dose beyond labeled instructions ONLY AS OR IF DIRECTED by provider
8.9 mg
Inject 89 units (8.9 mg) SQ weekly for weeks 1-4 Inject 1.11 mL (11.12 mg) SQ weekly for weeks 5-8 Inject 1.34 mL (13.35 mg) SQ weekly for weeks 9-12 Increase dose beyond labeled instructions ONLY AS OR IF DIRECTED by provider
11.12 mg
Inject 1.11 mL (11.12 mg) SQ weekly for weeks 1-4 Inject 1.34 mL (13.35 mg) SQ weekly for weeks 5-8 Inject 1.34 mL (13.35 mg) SQ weekly for weeks 9-12 Increase dose beyond labeled instructions ONLY AS OR IF DIRECTED by provider
13.35 mg
Inject 1.34 mL (13.35 mg) SQ weekly for weeks 1-4 Inject 1.34 mL (13.35 mg) SQ weekly for weeks 5-8 Inject 1.34 mL (13.35 mg) SQ weekly for weeks 9-12 Increase dose beyond labeled instructions ONLY AS OR IF DIRECTED by provider
15 mg
Inject 1.5 mL (15 mg) SQ weekly for weeks 1-4 Inject 1.5 mL (15 mg) SQ weekly for weeks 5-8 Inject 1.5 mL (15 mg) SQ weekly for weeks 9-12 Increase dose beyond labeled instructions ONLY AS OR IF DIRECTED by provider

Dosing Guide for Compounded Semaglutide (GLP-1) Injections

(LOCUMTELE)
*2.22 mg is the maximum dose/maintenance dose for Compounded Semaglutide (GLP-1) Injections **Increase dose beyond labeled instructions ONLY AS OR IF DIRECTED by provider.
WEEKLY DOSINGSIG / INJECTION INSTRUCTIONS
0.22 mg
Inject 9 units (0.22 mg) SQ weekly for weeks 1-4 Inject 18 units (0.44 mg) SQ weekly for weeks 5-8 Inject 18 units (0.44 mg) SQ weekly for weeks 9-12 Increase dose ONLY AS DIRECTED by provider (not to exceed 0.89 mg SQ weekly)
0.44 mg
Inject 18 units (0.44 mg) SQ weekly for weeks 1-4 Inject 36 units (0.89 mg) SQ weekly for weeks 5-8 Inject 36 units (0.89 mg) SQ weekly for weeks 9-12 Increase dose ONLY AS DIRECTED by provider (not to exceed 1.5 mg SQ weekly)
0.89 mg
Inject 36 units (0.89 mg) SQ weekly for weeks 1-4 Inject 60 units (1.5 mg) SQ weekly for weeks 5-8 Inject 60 units (1.5 mg) SQ weekly for weeks 9-12 Increase dose ONLY AS DIRECTED by provider (not to exceed 2 mg SQ weekly)
1.5 mg
Inject 60 units (1.5 mg) SQ weekly for weeks 1-4 Inject 80 units (2.0 mg) SQ weekly for weeks 5-8 Inject 80 units (2.0 mg) SQ weekly for weeks 9-12 Increase dose ONLY AS DIRECTED by provider (not to exceed 2.22 mg SQ weekly)
2 mg
Inject 80 units (2.0 mg) SQ weekly for weeks 1-4 Inject 89 units (2.22 mg) SQ weekly for weeks 5-8 Inject 89 units (2.22 mg) SQ weekly for weeks 9-12 Increase dose ONLY AS DIRECTED by provider (not to exceed 2.4 mg SQ weekly)
2.22 mg
Inject 89 units (2.22 mg) SQ weekly for weeks 1-4 Inject 89 units (2.22 mg) SQ weekly for weeks 5-8 Inject 89 units (2.22 mg) SQ weekly for weeks 9-12 Increase dose ONLY AS DIRECTED by provider (not to exceed 2.4 mg SQ weekly)

Dosing Guide for Compounded Tirzepatide (GLP-1/GIP) Injections

(LOCUMTELE)
*15 mg is the maximum dose/maintenance dose for Compounded Tirzepatide (GLP-1/GIP) Injections **Increase dose beyond labeled instructions ONLY AS OR IF DIRECTED by provider.
WEEKLY DOSINGSIG / INJECTION INSTRUCTIONS
2.22 mg
Inject 22 units (2.22 mg) SQ weekly for weeks 1-4 Inject 45 units (4.45 mg) SQ weekly for weeks 5-8 Inject 45 units (4.45 mg) SQ weekly for weeks 9-12 Increase dose ONLY AS DIRECTED by provider (not to exceed 6.67 mg SQ weekly)
4.45 mg
Inject 45 units (4.45 mg) SQ weekly for weeks 1-4 Inject 67 units (6.67 mg) SQ weekly for weeks 5-8 Inject 67 units (6.67 mg) SQ weekly for weeks 9-12 Increase dose ONLY AS DIRECTED by provider (not to exceed 8.90 mg SQ weekly)
6.67 mg
Inject 67 units (6.67 mg) SQ weekly for weeks 1-4 Inject 89 units (8.9 mg) SQ weekly for weeks 5-8 Inject 89 units (8.9 mg) SQ weekly for weeks 9-12 Increase dose ONLY AS DIRECTED by provider (not to exceed 11.12 mg SQ weekly)
8.9 mg
Inject 89 units (8.9 mg) SQ weekly for weeks 1-4 Inject 1.11 mL (11.12 mg) SQ weekly for weeks 5-8 Inject 1.11 mL (11.12 mg) SQ weekly for weeks 9-12 Increase dose ONLY AS DIRECTED by provider (not to exceed 13.35 mg SQ weekly)
11.12 mg
Inject 1.11 mL (11.12 mg) SQ weekly for weeks 1-4 Inject 1.34 mL (13.35 mg) SQ weekly for weeks 5-8 Inject 1.34 mL (13.35 mg) SQ weekly for weeks 9-12 Increase dose ONLY AS DIRECTED by provider (not to exceed 16.67 mg SQ weekly)
13.35 mg
Inject 1.34 mL (13.35 mg) SQ weekly for weeks 1-4 Inject 1.34 mL (13.35 mg) SQ weekly for weeks 5-8 Inject 1.34 mL (13.35 mg) SQ weekly for weeks 9-12 Increase dose ONLY AS DIRECTED by provider (not to exceed 16.67 mg SQ weekly)
15 mg
Inject 1.5 mL (15 mg) SQ weekly for weeks 1-4 Inject 1.5 mL (15 mg) SQ weekly for weeks 5-8 Inject 1.5 mL (15 mg) SQ weekly for weeks 9-12 Increase dose ONLY AS DIRECTED by provider (not to exceed 16.67 mg SQ weekly)

Evaluate side effects

Mild nausea, headaches, fatigue, constipation, and diarrhea are common when starting a new dosage and typically go away after a short period.
HOW WOULD YOU DESCRIBE YOUR SIDE EFFECTS?NEXT STEP:
None or manageable • Side effects are mild to none • They don't disrupt your daily life
Continue to Step 2.
Unmanageable • Side effects interfere with your daily life
Discontinue treatment and get in touch with your doctor ASAP.